Your search history is turned on.
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Ontario
FINANCIAL STATEMENT REQUEST FORM In accordance with the rules of National Instrument 51-102 Continuous Disclosure Obligations, effective March 30, 2004, a reporting issuer must send annually a request form to the registered holders and to the beneficial owners of its securities, that the registered holders and beneficial owners may use to request a copy of the reporting ...
AREV LIFE SCIENCES GLOBAL CORP. Form of Proxy Annual General Meeting Meeting to be held on Friday, April 5, 2024 Traders Bank Building 702, 67 Yonge Street Toronto ON M5E 1J8 Appointment of Proxyholder I/We being the undersigned holder(s) of AREV LIFE SCIENCES GLOBAL C...
1 | P a g e AREV LIFE SCIENCES GLOBAL CORP. INFORMATION CIRCULAR THIS INFORMATION CIRCULAR CONTAINS INFORMATION AS AT MARCH 1, 2024. This Information Circular is furnished in connection with the solicitation of Proxies by the management of the Company for use at the Annual General Meeting (the Meeting) of the shareholders of AREV LIFE SCIENCES GLOBAL CORP. (the C...
AREV LIFE SCIENCES GLOBAL CORP. NOTICE OF ANNUAL GENERAL MEETING NOTICE is hereby given that the Annual General Meeting (the Meeting) of AREV LIFE SCIENCES GLOBAL CORP. (the Company) will be held on Friday, April 5, 2024 via Freeconferencecall.com Meeting: https://hello.freeconference.com/conf/call/8185746 One tap mobile: +1 605-475-4120, 8185746# Dial-in using your phone...
Date: February 6, 2024 Jurisdictions: Alberta, British Columbia, Ontario
AREV Life Sciences Global Corp. | [email protected] | 778-896-6536 | arevlifesciences.com 1 AREV LIFE SCIENCES GLOBAL CORP. PRESS RELEASE AREV Announces Significant Corporate Progress Amid Trading Suspension VANCOUVER, BC / February 6 , 2024 / AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (AREV or the Com- pa...
Date: February 5, 2024 Jurisdictions: Alberta, British Columbia, Ontario
To All Applicable Exchanges and Securities Administrators Subject: Arev Life Sciences Global Corp. (the "Issuer") Notice of Meeting and Record Date Dear Sir/Madam: Annual General Meeting April 5, 2024 March 1, 2024 March 1, 2024 March 1, 2024 Common Shares CA04019J1093 No No No No Yours truly, Odyssey Tru...
Date: December 8, 2023 Jurisdictions: Alberta, British Columbia, Ontario
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Denby Greenslade, the Chief Financial Officer of AREV Life Sciences Global Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of AREV Life Sciences Global Corp. (the issuer) for the interim period e...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Mike Withrow, the Chief Executive Officer of AREV Life Sciences Global Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of AREV Life Sciences Global Corp. (the issuer) for the interim period ended...
1 Global Corp. (Formerly AREV Nanotec Brands Inc.) MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 Dated as of December 8, 2023. (All amounts expressed in CAD dollars, unless otherwise stated) CAUTIONARY NOTE REGARDING FORWARDING LOOKING STATEMENTS This Managements Discussion...
AREV LIFE SCIENCES GLOBAL CORP. (FORMERLY AREV NANOTEC BRANDS INC.) CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the nine months ended September 30, 2023 (Expressed in Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS Under ...